SHIVA ADHAM: Open Payments
NPI 1003488214 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 15 payments from 6 companies in 2025. Trend: 2023 $327 · 2024 $1,178 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Travere Therapeutics, Inc. | 3 | $63 |
| Ardelyx, Inc. | 2 | $50 |
| Amgen Inc. | 1 | $32 |
Products named: TARPEYO, JYNARQUE, Fabhalta, IBSRELA, KRYSTEXXA.
Industry payments across NV — which companies pay providers there.
